Literature DB >> 9555210

Endoscopically controlled sinus floor augmentation. A preliminary report.

W Engelke1, I Deckwer.   

Abstract

Sinus augmentation has been advocated to be a surgical technique with predictable results in peri-implant surgery. Endoscopic surgery of the maxillary sinus so far has been used as diagnostic procedure. In this paper, the use of endoscopy is described as a low invasive adjunctive technique in sinus floor augmentation. After preparation of the mucoperiosteum, bone grafts can be placed under endoscopic control between sinus floor and mucoperiosteum. A laterobasal approach via a small osteotomy and a transalveolar approach are possible for mucosal elevation and graft placement. First clinical results are reported. Endoscopic sinus lift may contribute to a reduction of perioperative morbidity, reduction of oroantral fistulae and control of graft position. The less invasive technique may allow to extend the indication for sinus augmentation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9555210     DOI: 10.1034/j.1600-0501.1997.080612.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  13 in total

Review 1.  ENT assessment in the integrated management of candidate for (maxillary) sinus lift.

Authors:  L Pignataro; M Mantovani; S Torretta; G Felisati; G Sambataro
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-06       Impact factor: 2.124

2.  Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions.

Authors:  Mahesh H Mankani; Sergei A Kuznetsov; Grayson W Marshall; Pamela Gehron Robey
Journal:  Tissue Eng Part A       Date:  2008-12       Impact factor: 3.845

3.  Sinus floor augmentation using miniscrew and in situ hardening biomaterial: method and case report.

Authors:  Wilfried Engelke; Ramón Fuentes; Víctor Beltrán
Journal:  Int J Clin Exp Med       Date:  2014-06-15

4.  Comparison of three different methods of internal sinus lifting for elevation heights of 7 mm: an ex vivo study.

Authors:  Aghiad Yassin Alsabbagh; Mohammed Monzer Alsabbagh; Batol Darjazini Nahas; Salam Rajih
Journal:  Int J Implant Dent       Date:  2017-09-04

5.  Coalescence of inter: Osteotomy bone graft material inserted via separate transcrestal sinus osteotomies: A case report and concise review of the literature.

Authors:  Shane J J McCrea
Journal:  Eur J Dent       Date:  2014-10

Review 6.  Visualization techniques of the inferior alveolar nerve (IAN): a narrative review.

Authors:  Annelies Weckx; Jimoh Olubanwo Agbaje; Yi Sun; Reinhilde Jacobs; Constantinus Politis
Journal:  Surg Radiol Anat       Date:  2015-07-12       Impact factor: 1.246

Review 7.  Endoscopically controlled flapless transcrestal sinus floor elevation with platelet-rich fibrin followed by simultaneous dental implant placement: A case report and literature review.

Authors:  Zhenzhen Liu; Chunyan Li; Jing Zhou; Xiaolin Sun; Xue Li; Manlin Qi; Yanmin Zhou
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

8.  Minimally invasive endoscopic maxillary sinus lifting and immediate implant placement: A case report.

Authors:  Mahmoud Mudalal; Xiao-Lin Sun; Xue Li; Jiao Fang; Man-Lin Qi; Jia Wang; Liu-Yi Du; Yan-Min Zhou
Journal:  World J Clin Cases       Date:  2019-05-26       Impact factor: 1.337

9.  The endoscopically assisted transcrestal sinus floor elevation with platelet-rich fibrin at an immediate implantation of periapical lesion site: A case report.

Authors:  Hanchi Wang; Jia Wang; Tianqi Guo; Xinxin Ding; Wanqi Yu; Jinghui Zhao; Yanmin Zhou
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

10.  Sinus Floor Elevation via an Osteotome Technique without Biomaterials.

Authors:  Rodrigo Andrés-García; José Vicente Ríos-Santos; Mariano Herrero-Climent; Pedro Bullón; Javier Fernández-Farhall; Alberto Gómez-Menchero; Ana Fernández-Palacín; Blanca Ríos-Carrasco
Journal:  Int J Environ Res Public Health       Date:  2021-01-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.